Show Notes
<p>In this episode, Richard Young speaks with Terttu Haring and Leonie Christianson from Syneos Health. Nowadays, clinical data managers have the tools to collect novel insights from large volumes of data. But has this influx of data and tech caused us to move farther away from the patients we serve?</p> <p>Together Terttu, Leonie, and Richard outline the major opportunities for life sciences organizations to put patients back at the heart of clinical strategy. </p> <p>Subscribe to State of Digital Clinical Trials, a Veeva podcast, to get new episodes as soon as they are released.</p> <p><br></p>
More from Unblinded: A Clinical Trial Podcast
Manny is joined by guest Jack Evans, VP Europe at Civia Health, to discuss the operational realities, systemic burdens, and collaborative opportunities between clinical trial sponsors, CROs, and research sites. Jack highlights the challenges of setting up a research site in Europe, and what they need from sponsors to help make clinical trials more efficient.
In this episode Danielle Drachmann, CEO of Ketotic Hypoglycemia International, and Senior Patient Partnering Manager at Thermo Fisher Scientific, explains how lived experience can – and should – reshape clinical research from day one. Danielle shares her powerful personal journey from kindergarten teacher to founder of a global rare disease organization after fighting for answers for her children.
In this episode, Novo Nordisk’s Rhona O'Donnell and Ibrahim Kamstrup-Akkaoui explore how the combination of open source tools and AI is reshaping the future of clinical data management. From the creation of OpenStudyBuilder to the potential of Veeva’s agentic AI layer, they discuss breaking down traditional industry silos to get treatments to patients faster.
In this episode of Unblinded, host Manny Vazquez is joined by Leianne Ebert, Head of Data Operations at Alcon, and co-host John Acampado, Senior Director of Clinical Strategy for Veeva MedTech. Together, they explore the regulatory differences between pharma and medical device trials, data standards, and the industry’s digital maturity. Leianne and John also provide a reality check on AI readiness, debating the "deep pockets, short arms" mentality of the industry, and end with a call to action for systemic technology adoption.
Joel White, owner of Marketcap Consulting, together with Veeva’s Chris Kreitel, joins Manny to discuss why the next era of clinical trial outsourcing will be defined by technology integration and economic agility. They debate whether CROs are the ultimate masters of integrating tech, and the role of small biotechs as growth drivers in the market.